Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
23.88
-0.34 (-1.40%)
At close: May 14, 2025, 4:00 PM
23.97
+0.09 (0.38%)
After-hours: May 14, 2025, 7:49 PM EDT
Koninklijke Philips Market Cap
Koninklijke Philips has a market cap or net worth of $22.30 billion as of May 14, 2025. Its market cap has increased by 16.77% in one year.
Market Cap
22.30B
Enterprise Value
29.48B
1-Year Change
16.77%
Ranking
Category
Stock Price
$23.88
Market Cap Chart
Since December 1, 1998, Koninklijke Philips's market cap has increased from $15.62B to $22.30B, an increase of 42.79%. That is a compound annual growth rate of 1.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 13, 2025 | 22.40B | -2.38% |
Dec 31, 2024 | 22.95B | 11.60% |
Dec 29, 2023 | 20.56B | 57.66% |
Dec 30, 2022 | 13.04B | -60.89% |
Dec 31, 2021 | 33.35B | -30.89% |
Dec 31, 2020 | 48.26B | 8.19% |
Dec 31, 2019 | 44.61B | 37.19% |
Dec 31, 2018 | 32.52B | -7.46% |
Dec 29, 2017 | 35.14B | 23.45% |
Dec 30, 2016 | 28.46B | 19.64% |
Dec 31, 2015 | 23.79B | -12.24% |
Dec 31, 2014 | 27.11B | 42.97% |
Dec 30, 2011 | 18.96B | -31.76% |
Dec 31, 2010 | 27.79B | 4.28% |
Dec 31, 2009 | 26.65B | 48.16% |
Dec 31, 2008 | 17.98B | -53.52% |
Dec 31, 2007 | 38.69B | 13.76% |
Dec 29, 2006 | 34.01B | 20.84% |
Dec 30, 2005 | 28.15B | 17.36% |
Dec 31, 2004 | 23.99B | -8.90% |
Dec 31, 2003 | 26.33B | 64.54% |
Dec 31, 2002 | 16.00B | -39.26% |
Dec 31, 2001 | 26.35B | -19.70% |
Dec 29, 2000 | 32.81B | 7.41% |
Dec 31, 1999 | 30.55B | 83.48% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 669.76B |
Johnson & Johnson | 357.16B |
AbbVie | 332.08B |
Novo Nordisk | 291.59B |
UnitedHealth Group | 282.47B |
Abbott Laboratories | 224.53B |
Novartis AG | 209.81B |
AstraZeneca | 209.59B |